New injection tested for aggressive lung cancer

NCT ID NCT06598306

Recruiting now Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether tarlatamab, given as an injection under the skin, is safe and tolerable for people with extensive stage small cell lung cancer that has worsened after initial treatment. The study will enroll about 220 adults to monitor side effects and see if the treatment shows any signs of shrinking tumors. Researchers will also measure how the drug moves through the body and how long it stays active.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Adana Sehir Egitim ve Arastirma Hastanesi
RECRUITING

Adana, 01370, Turkey (Türkiye)
Ankara Bilkent Sehir Hastanesi
RECRUITING

Ankara, 06800, Turkey (Türkiye)
Avera Cancer Institute
RECRUITING

Sioux Falls, South Dakota, 57105, United States
Calvary Mater Newcastle Hospital
RECRUITING

Waratah, New South Wales, 2298, Australia
Centre Hospitalier Universitaire de Liege - Sart Tilman
RECRUITING

Liège, 4000, Belgium
Chris OBrien Lifehouse
RECRUITING

Camperdown, New South Wales, 2050, Australia
Freiburg Spital
RECRUITING

Fribourg, 1708, Switzerland
Hospital Regional Universitario de Malaga
RECRUITING

Málaga, Andalusia, 29011, Spain
Hospital Universitari Vall d Hebron
RECRUITING

Barcelona, Catalonia, 08035, Spain
Hospital Universitari i Politecnic La Fe
RECRUITING

Valencia, Valencia, 46026, Spain
Hospital Universitario 12 de Octubre
RECRUITING

Madrid, 28041, Spain
Instytut Centrum Zdrowia Matki Polki
RECRUITING

Lodz, 93-338, Poland
Kantonsspital Graubuenden
RECRUITING

Chur, 7000, Switzerland
Kantonsspital Winterthur
RECRUITING

Winterthur, 8401, Switzerland
Koc Universitesi Hastanesi
RECRUITING

Istanbul, 34010, Turkey (Türkiye)
Okayama University Hospital
RECRUITING

Okayama, Okayama-ken, 700-8558, Japan
Shanghai Pulmonary Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200433, China
Swedish Cancer Institute
RECRUITING

Seattle, Washington, 98104, United States
The Alfred Hospital
RECRUITING

Melbourne, Victoria, 3004, Australia
Trinity Health Saint Joseph Mercy Ann Arbor
RECRUITING

Ann Arbor, Michigan, 48106, United States
Universitaetsklinikum Regensburg
RECRUITING

Regensburg, 93053, Germany
Universitaetsklinikum Wuerzburg
RECRUITING

Würzburg, 97078, Germany
Universitair Ziekenhuis Gent
RECRUITING

Ghent, 9000, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
RECRUITING

Leuven, 3000, Belgium
University of Illinois Chicago
RECRUITING

Chicago, Illinois, 60612, United States
University of Southern California, Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States
University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Uniwersyteckie Centrum Kliniczne
RECRUITING

Gdansk, 80-214, Poland
Wakayama Medical University Hospital
RECRUITING

Wakayama, 641-8509, Japan
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu
RECRUITING

Przemyśl, 37-700, Poland

Conditions

Explore the condition pages connected to this study.

EXTENSIVE STAGE SMALL CELL LUNG CANCER